# RNN 2nd Gen Model Humana Inc. Hospital & medical service plans

Stock predictor AI models:
Subscribe >> Deal exit on
July 22, 2020
Deal entry on
July 22, 2020
5.79%Expected margin
67.92% successful of 53 deals
$ 415.77 Last close price
at 11-aug-2020


Model's trade recommendations No return for period yet

-25.98% Annual return

$39.61B Market Cap

β 0.95  


Model (following trade recommendations)


Underlying stock

S&P 500

Return for period
52wk return -53.26%
52wk Range
Sortino ratio -0.72
Sharpe ratio -0.70
Norm. RMSE 5.07%
Downside risk 32.46%
Volatility 0.00%
  • 2.00 (0.70%) Div (Yield)
  • STRONG BUY Analysts consensus recommendation

Humana Inc. is committed to helping their millions of medical and specialty members achieve their best health. Their successful history in care delivery and health plan administration is helping them create a new kind of integrated care with the power to improve health and well-being and lower costs. Their efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large.

Industry sector: Medical

Sector classification: Hospital & medical service plans

Deep Learning based analysis and prediction model for Humana Inc. (HUM) stock is a 2nd Generation Non-linear Autoregressive (NAR) model based on the LSTM/GRU Recurrent Neural Network architecture.

Model is in the production pipeline since Sept. 30, 2015.

Market data for HUM model training are being downloaded from the Quandl premium datasets on a daily basis.
Risks related to the novel coronavirus disease 2019 (COVID-19) caused by the virus named “SARS-CoV-2” are accounted for in this model in the form of the historical data coincided with outbreaks and other global events in the past used to train ML prediction model for HUM.

Model is being retrained on a regular basis.

Float 137M
P/E 23.39
Shares Outstanding 138M
% Held by Insiders 0.60%
% Held by Institutions 96.61%
EPS (last reported FY) $11.71
EPS (last reported Q) $3.36
EPS, estimated (last reported Q) $3.21
Total revenues $54 B
Net income $2 B